Muenchen Klinik Neuperlach, Klinik fuer Haematologie und Onkologie

Munich, Bavaria 81737

0 studies enrolling now · 3 studies all time

What they study most

Metastatic Colorectal Cancer, Neoplasms

Studies at this site

• A Study of Encorafenib Plus Cetuximab Taken Together With Pembrolizumab Compared to Pembrolizumab Alone in People With Previously Untreated Metastatic Colorectal Cancer — Running, not enrolling
• A Study of Encorafenib Plus Cetuximab With or Without Chemotherapy in People With Previously Untreated Metastatic Colorectal Cancer — Running, not enrolling
• ZN-c3 in Adult Participants With Metastatic Colorectal Cancer — Stopped early